IP-Watch Seeks Part-Time Fundraising/Outreach Expert

ipw-logo-squre

Intellectual Property Watch is seeking a dynamic person to help expand our fundraising and outreach activities.

WHO Heralds Breakthrough On Ebola Vaccine: “Turning Point In History Of Health R&D”

ebola vaccine

The World Health Organization announced today that a vaccine preventing Ebola has proved efficacious in Ebola-stricken Guinea, hailing it as a “turning point in the history of health R&D.”

Medicines Patent Pool At 5 Years: Promises Kept, Changes Ahead – An Interview With Greg Perry

MPPF-LOGO_2_COLORS

The Medicines Patent Pool in Geneva is celebrating five years of existence this month. MPP Executive Director Greg Perry sat down with Intellectual Property Watch Catherine Saez to describe progress made since its inception, the success of its licensing agreement model, and plans for the future, including a possible extension to other diseases such as tuberculosis and hepatitis C.

WIPO Patent Committee Searching For Common Ground For Future Discussions

SCP Chair Bucura Ionescu of Romania

After a slow start this week due to late approval of the agenda, the World Intellectual Property Organization patent law committee is now sailing through the proposed schedule. However, previous positions remain unchanged and the core issue of the session is to find common ground on the future work of the committee.

Panel: Biotech Industry Executives Shine Light On Their IP Management Strategies

Speakers at the biotech industry side event at WIPO

“IP is a very crucial part of our business and I can’t imagine being in biotech without a very strong emphasis on intellectual property,” a biotech industry executive said during a panel organised at the World Intellectual Property Organization yesterday.

South Africa Draft Copyright Amendment Bill Published For Public Comment

south_africa_cape_town_table_mountain_12

The publication for public comment of the much-anticipated South African draft Copyright Amendment Bill has cautiously been welcomed by some stakeholders, who believe that parts of the draft are unworkable.

Ukraine Open Access Initiative Roils Local Authors Seeking Copyright Protection

Vladimir Groisman, head of Ukraine's Verkhovna Rada and an author of the new initiative

It may be an open access initiative, but Ukrainian writers and authors are on the verge of massive protests, due to a recent initiative of the Ukrainian Parliament (Verkhovna Rada) to conduct digitalisation and online publishing of all of the books and documents stored in the national archives and libraries.

Decision Time On Biologics Exclusivity: Eight Years Is No Compromise

tppBanner

Burcu Kilic and Courtney Pine write: As the Trans-Pacific Partnership (TPP) negotiations approach their endgame, biologics exclusivity is still considered “one of the most difficult outstanding issues in the negotiation.”[2] Pharmaceutical companies seek longer data and marketing exclusivities to further delay market entry of cost-saving biosimilar drugs. Data exclusivity prevents follow-on pharmaceutical developers from relying on originators’ test data submitted for marketing approval while seeking such approval for its own product. The World Trade Organization’s (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) requires some protection against unfair competition for this sort of data, but it does not require countries to adopt rules conveying exclusive rights over it in the same way as it does regarding patents.[3] Currently, the US provides 12 years of exclusivity for new biological products under the Biologics Price Competition and Innovation Act (BPCIA).[4] The provision providing 12 years exclusivity was buried inside the 20,000-page healthcare law, The Patient Protection and Affordable Care Act. A robust debate over what would be an appropriate exclusivity period, if any, was overshadowed by other controversial aspects of the bill commonly referred to as Obamacare.

Intellectual Property Law Under The Prism Of The Right To Culture

ceipi logo

STRASBOURG, FRANCE – Although the right to science and culture has been enshrined in several international treaties, their exact implications in the intellectual property field have remained vague.

Is The European Unitary Patent System On Its Way To A Tepid Start?

EPO President Benoit Battistelli

For nearly two decades, the European Union has pondered the completion of a unitary patent system (UP) and a Unitary Patent Court (UPC). But even after the European Court of Justice has ruled the UP/UPC agreement to be constitutional, users, including some big ones, remain cautious.